<DOC>
	<DOCNO>NCT02125981</DOCNO>
	<brief_summary>The limaprost alfadex improve surgical outcome patient cervical myelopathy .</brief_summary>
	<brief_title>The Study About Efficacy Oral Limaprost After Surgery Cervical Myelopathy</brief_title>
	<detailed_description />
	<mesh_term>Spinal Cord Diseases</mesh_term>
	<mesh_term>Bone Marrow Diseases</mesh_term>
	<mesh_term>Alprostadil</mesh_term>
	<criteria>Older 20 year old Compressive cervical myelopathy , confirm MRI , include C1C2 instability , ossification posterior longitudinal ligament Plan undergo cervical surgery myelopathy JOA score less 15 point Signed informed consent patient legal guardian Infection malignancy Taking Limaprost surgery Pregnancy expect pregnant breast feeding severe cardiovascular , pulmonary , renal disease distress , brain pathology relate coagulopathy drug cause bleeding tendency severe pain disease significant disease disorder , opinion Investigator , may either put participant risk participation study , may influence result study patient follow study protocol , reason</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>limaprost alfadex</keyword>
	<keyword>cervical myelopathy</keyword>
	<keyword>surgery</keyword>
</DOC>